← Scroll for more →
Lifevantage Corp (LFVN)
Pharmaceutical Preparations
Latest Price
$6.30
TTM P/E
13.70
Normalized P/E
19.29
Div Yield
2.94%
Book Value
2.61
P/B Ratio
2.42
Valuation metrics
adjust assumptions →EPS: $0.40
Book value / share: $2.68
Formula: √(22.5 × EPS × BVPS)
Graham Number
$4.91
22% downside
Norm. op. income: $8M (median of 7yr)
Tax rate: 25%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$5.72
9% downside
Base FCF: $7M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$3.46
45% downside
EPS: $0.40
Target P/E: 19×
Formula: EPS × P/E
P/E Fair Value
$7.60
+21% upside
Institutional Ownership
46.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Capital Management Corp | 1.88M | $11.0M | 15.01% | -563.5K | 2026-06-30 |
| Renaissance Technologies LLC | 669.4K | $4.0M | 5.35% | -198.3K | 2026-06-30 |
| Vanguard Capital Management LLC | 429.2K | $2.0M | 3.43% | -219 | 2026-06-30 |
| BlackRock, Inc. | 268.6K | $1.0M | 2.15% | -501.1K | 2026-06-30 |
| Dimensional Fund Advisors LP | 256.3K | $1.0M | 2.05% | -19.9K | 2026-06-30 |
| Envestnet Asset Management Inc | 229.9K | $1.0M | 1.84% | +10.7K | 2026-06-30 |
| Jane Street Group, LLC | 203.7K | $1.0M | 1.63% | +162.4K | 2026-06-30 |
| Citadel Advisors LLC | 172.5K | $1.0M | 1.38% | +96.0K | 2026-06-30 |
| American Century Companies Inc | 144.4K | -- | 1.15% | +39.7K | 2026-06-30 |
| Geode Capital Management, LLC | 120.8K | -- | 0.97% | -140.4K | 2026-06-30 |